EP0093: An Open-Label, Multicenter, Extension Study to Evaluate the Safety and Efficacy of Padsevonil (the "Study Product") as Adjunctive Treatment of Foca-Onset Seizures in Adult Subjects with Drug-Resistent Epilepsy

Grants and Contracts Details

StatusFinished
Effective start/end date12/6/192/18/21

Funding

  • Parexel International LLC: $14,767.00